Close Menu

NEW YORK – Natera said on Thursday after the close of the market that its third quarter revenues grew 26 percent year over year, driven by an overall increase in testing volumes, particularly in reproductive health.

Revenues for the three months ended Sept. 30 totaled $98.1 million, up from $77.9 million a year ago and besting the average Wall Street estimate of $87.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.